Amicus Therapeutics

4 Healthcare Stock Stories Starting Off the Short Week

4 Healthcare Stock Stories Starting Off the Short Week

Wall St. Cheat Sheet

3 Horrendous Health-Care Stocks This Week

3 Horrendous Health-Care Stocks This Week

Motley Fool

Amicus Therapeutics slumps on new Fabry drug data

Amicus Therapeutics slumps on new Fabry drug data

Yahoo/AP

Amicus Therapeutics: One Biotech Firm Making Considerable Strides In Terms Of Pompe Disease

Amicus Therapeutics: One Biotech Firm Making Considerable Strides In Terms Of Pompe Disease

Seeking Alpha

Amicus Theraputics announces positive results from Phase 2 Chaperone-ERT study

Amicus Theraputics announces positive results from Phase 2 Chaperone-ERT study

The Fly on the Wall

3 Horrendous Health-Care Stocks This Week

3 Horrendous Health-Care Stocks This Week

Motley Fool

3 Humongous Health-Care Stocks This Week

3 Humongous Health-Care Stocks This Week

Motley Fool

Amicus Therapeutics Poised For Rebound Into December Phase III Results

Amicus Therapeutics Poised For Rebound Into December Phase III Results

Seeking Alpha

Here are 5 Biopharmaceutical Companies on the Rise

Here are 5 Biopharmaceutical Companies on the Rise

Wall St Cheat Street

5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments

5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments

Seeking Alpha